ADAM10 and Alzheimer disease: In addition, we report that activation of ADAM10 does not result in a decrease in Aβ levels in the human iPSC-derived neurons, a result consistent with the results from a study following acitretin administration in humans (37) and highlighting that human iPSC-derived neurons are a valuable model system to explore the mechanisms underlying AD.